PSCA and neoplasm: Topfer K et al. reported that NK cells expressing the prostate stem cell antigen (PSCA)-specific CAR with a DAP-12 signaling motif, showed a higher antitumor activity in vitro and completely eradicated PSCA+ tumor cells in mice compared to NK cells engineered with CAR carrying only the CD3ζ chain [121].